This human clinical study examined injectable therapeutic peptides, specifically BPC-157, as potential adjuncts to regenerative medicine and sports performance applications. The research evaluated how these peptides might support tissue repair and recovery in musculoskeletal contexts. The evidence level is human clinical, providing direct clinical observations regarding peptide therapeutic potential in these populations.